Your browser doesn't support javascript.
loading
Fibroblast Activation Protein Inhibitor-Based Radionuclide Therapies: Current Status and Future Directions.
Ora, Manish; Soni, Neetu; Nazar, Aftab Hasan; Dixit, Manish; Singh, Rohit; Puri, Savita; Graham, Michael M; Gambhir, Sanjay.
Affiliation
  • Ora M; Department of Nuclear Medicine, SGPGIMS, Lucknow, India; drmanishora@yahoo.com.
  • Soni N; Department of Radiology, University of Rochester Medical Center, Rochester, New York.
  • Nazar AH; Department of Nuclear Medicine, SGPGIMS, Lucknow, India.
  • Dixit M; Department of Nuclear Medicine, SGPGIMS, Lucknow, India.
  • Singh R; Division of Hematology-Oncology, University of Vermont Medical Center, Burlington, Vermont; and.
  • Puri S; Department of Radiology, University of Rochester Medical Center, Rochester, New York.
  • Graham MM; Division of Nuclear Medicine, Department of Radiology, University of Iowa Health Care, Iowa City, Iowa.
  • Gambhir S; Department of Nuclear Medicine, SGPGIMS, Lucknow, India.
J Nucl Med ; 64(7): 1001-1008, 2023 07.
Article in En | MEDLINE | ID: mdl-37268422
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cancer-Associated Fibroblasts / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Nucl Med Year: 2023 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cancer-Associated Fibroblasts / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Nucl Med Year: 2023 Document type: Article Country of publication: Estados Unidos